Patents by Inventor Jacob D. Johnson

Jacob D. Johnson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11969788
    Abstract: A method of manufacturing an antenna assembly includes additively manufacturing an element that is a monolithic structure and that includes (i) a ground plane including one or more aperture slots, (ii) a patch antenna above the ground plane, and (iii) a sacrificial support feature to support the patch antenna above the ground plane. The method further includes applying a dielectric material between the ground plane and the patch antenna. In an example, applying the dielectric material between the ground plane and the patch antenna includes providing a dielectric foam between the ground plane and the patch antenna, where the dielectric foam at least in part supports the patch antenna above the ground plane. The method further includes removing at least a section of the sacrificial support feature, such that any remnant of the support feature does not physically couple the ground plane to the patch antenna.
    Type: Grant
    Filed: January 25, 2023
    Date of Patent: April 30, 2024
    Assignee: BAE Systems Information and Electronic Systems Integration Inc.
    Inventors: Jean L. Kubwimana, Alexander D. Johnson, Jacob Tamasy, James F. Fung, Matthew J. Ney
  • Publication number: 20240116386
    Abstract: Utility vehicles include ground engaging members, a frame supported by the ground engaging members, a motor supported by the frame operably coupled to the ground engaging members, and a battery configured to provide electrical power to the motor. The battery may be removable and configured to be easily charged by outside power sources such as generators and external batteries. A charger may be configured to receive instructions to charge the battery using a specific charger operating characteristic. The vehicle may also include a variety of accessory ports configured to electrically couple to accessories that use AC or DC power.
    Type: Application
    Filed: October 5, 2023
    Publication date: April 11, 2024
    Applicant: Polaris Industries Inc.
    Inventors: Yassin M. Kelay, David F. Buehler, Chiao George Liu, Aaron D. Deckard, Jacob Gerten, Benjamin R. Bauer, Akshay A. Biyani, Naval K. Agrawal, Kathryn L. Johnson, Austin A. Holt
  • Patent number: 8691801
    Abstract: Manzamine compounds have been discovered to decrease cell dissociation and cell migration associated with the metastatic potential of cancer cells and a restoration of cancer cell susceptibility to agents, such as TRAIL, which can induce apoptosis. Specifically, Manzamine A has a formerly unrecognized utility in both blocking tumor cell invasion and tumor metastasis as well in restoring cancer cell susceptibility to standard chemotherapeutic agents which induce apoptosis and, therefore, has utility in treating cancer.
    Type: Grant
    Filed: July 17, 2012
    Date of Patent: April 8, 2014
    Assignee: Florida Atlantic University Board of Trustees
    Inventors: Esther A. Guzman, Jacob D. Johnson, Amy E. Wright
  • Publication number: 20120289533
    Abstract: Manzamine compounds have been discovered to decrease cell dissociation and cell migration associated with the metastatic potential of cancer cells and a restoration of cancer cell susceptibility to agents, such as TRAIL, which can induce apoptosis. Specifically, Manzamine A has a formerly unrecognized utility in both blocking tumor cell invasion and tumor metastasis as well in restoring cancer cell susceptibility to standard chemotherapeutic agents which induce apoptosis and, therefore, has utility in treating cancer.
    Type: Application
    Filed: July 17, 2012
    Publication date: November 15, 2012
    Inventors: Esther A. Guzman, Jacob D. Johnson, Amy E. Wright
  • Patent number: 8232266
    Abstract: Manzamine compounds have been discovered to decrease cell dissociation and cell migration associated with the metastatic potential of cancer cells and a restoration of cancer cell susceptibility to agents, such as TRAIL, which can induce apoptosis. Specifically, Manzamine A has a formerly unrecognized utility in both blocking tumor cell invasion and tumor metastasis as well in restoring cancer cell susceptibility to standard chemotherapeutic agents which induce apoptosis and, therefore, has utility in treating cancer.
    Type: Grant
    Filed: February 20, 2007
    Date of Patent: July 31, 2012
    Assignee: Florida Atlantic University Board of Trustees
    Inventors: Esther A. Guzman, Jacob D. Johnson, Amy E. Wright